Search details
1.
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer.
Future Oncol
; 20(8): 423-436, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37387213
2.
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1709-1723, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36625938
3.
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol
; 21(11): 1455-1464, 2020 11.
Article
in English
| MEDLINE | ID: mdl-33152285
4.
Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
Breast Cancer Res
; 22(1): 45, 2020 05 13.
Article
in English
| MEDLINE | ID: mdl-32404150
5.
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.
Breast Cancer Res
; 21(1): 108, 2019 09 18.
Article
in English
| MEDLINE | ID: mdl-31533777
6.
Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2.
Oncologist
; 24(7): 893-900, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30679318
7.
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1725-1726, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36809405
8.
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy.
BMC Med
; 13: 303, 2015 Dec 18.
Article
in English
| MEDLINE | ID: mdl-26684470
9.
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population.
Oncology
; 86(1): 16-21, 2014.
Article
in English
| MEDLINE | ID: mdl-24335608
10.
Current status of fertility preservation in a Spanish tertiary public hospital: multidisciplinary approach and experience in over 1500 patients.
Clin Transl Oncol
; 26(5): 1129-1138, 2024 May.
Article
in English
| MEDLINE | ID: mdl-37872422
11.
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
EBioMedicine
; 102: 105043, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38447275
12.
Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.
Oncologist
; 18(2): 123-33, 2013.
Article
in English
| MEDLINE | ID: mdl-23404817
13.
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
Breast Cancer Res Treat
; 142(2): 237-55, 2013 Nov.
Article
in English
| MEDLINE | ID: mdl-24162158
14.
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
J Natl Cancer Inst
; 115(3): 332-336, 2023 03 09.
Article
in English
| MEDLINE | ID: mdl-36576009
15.
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer.
Nat Commun
; 14(1): 1157, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36859416
16.
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients.
J Cell Biochem
; 113(6): 2122-5, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22298331
17.
Gene expression profiles of breast cancer metastasis according to organ site.
Mol Oncol
; 16(1): 69-87, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34051058
18.
Stratifying triple-negative breast cancer: which definition(s) to use?
Breast Cancer Res
; 13(2): 105, 2011 Apr 01.
Article
in English
| MEDLINE | ID: mdl-21457488
19.
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases.
Breast Cancer Res
; 13(6): R125, 2011.
Article
in English
| MEDLINE | ID: mdl-22132754
20.
Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy.
EBioMedicine
; 69: 103451, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-34161883